Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-039888·Altamira Therapeutics Ltd.
Schedule 13D ownership disclosure
ALTAMIRA THERAPEUTICS LTD
Common Stock, par value $0.002 per share · CUSIP: G0360L134
Event date: 2025-04-30
- Filing-level shares
- 1,079,843.00
- Percent of class
- 18.9%
- Thomas MeyerReported CIK 0001616410
Shares: 1,079,843.00 · Class: 18.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-039888
- Form type
- SCHEDULE 13D/A
- Filer
- Altamira Therapeutics Ltd.
- CIK
- CIK 1601936
- Filed
- May 06, 2025
- Reporting period
- Apr 30, 2025
- Description
- Schedule 13D beneficial ownership